Abstract
Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies are drugs that could change the course of the disease in cystic fibrosis (CF) patients and also nutrition status and glucose metabolism. Our study aimed to assess the impact of CFTR modulators treatment on nutritional and glucose status in CF pediatric patients with different glucose tolerance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
